AIBN research facility BASE hosted an RNA Afternoon on April 7, with Australian experts discussing mRNA therapy advances – and impacts such as on liver disease treatment.
The success of the COVID-19 mRNA vaccines has demonstrated the potential of RNA therapies – and the University of Queensland is driving research and developing facilities to realise the potential.
Flat batteries could be a thing of the past thanks to lithium-ion battery nanotechnology developed by UQ. Professor Lianzhou Wang and his team from have demonstrated a battery that remains stable for more than 1000 charge/discharge cycles.
Tiny ‘live’ brain models are being used at The University of Queensland to study a condition causing high-functioning young people with Down Syndrome to suddenly regress.
On International Womens’ Day, we asked AIBN’s Associate Professor Joy Wolfram what advice she would give to her 16-year-old self if she could mentor a younger Joy.
The success of mRNA vaccines and cell therapies has highlighted the importance of biotechnology, and AIBN has helped kick-start the process for establishing a biomanufacturing ecosystem for Queensland.
Almost 30 AIBN Scientists submitted entries to the 2021 AIBN image contest, highlighting the role imagination and creativity play in scientific research.
Studying tiny ‘live’ models of the human brain has helped researchers understand its ageing and find a key to potential treatments neurodegenerative diseases.
The UQ Foundation Research Excellence Awards (FREA) scheme is a means by which the University recognises demonstrated excellence and promise of future success in research.
Researchers studying ageing in tiny ‘live’ models of the human brain have found a key to potential treatments for Alzheimer’s and other neurodegenerative diseases.
Improving a “trial-and-error approach’’ to epilepsy treatment is the aim of research that encompasses stem cells, artificial intelligence, brain organoids and drug screening.
Needle-free technology, originally developed at the AIBN, has been used to administer a COVID-19 vaccine candidate to successfully protect mice, demonstrating the potential of non-invasive delivery.